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Abstract
Microplusin is an antimicrobial peptide isolated from the cattle tick Rhipiceph-
alus (Boophilus) microplus. Its copper-chelating ability is putatively responsible
for its bacteriostatic activity against Micrococcus luteus as microplusin inhibits
respiration in this species, which is a copper-dependent process. Microplusin is
also active against Cryptococcus neoformans (MIC50 = 0.09 lM), the etiologic
agent of cryptococcosis. Here, we show that microplusin is fungistatic to
C. neoformans and this inhibitory effect is abrogated by copper supplemen-
tation. Notably, microplusin drastically altered the respiratory profile of
C. neoformans. In addition, microplusin affects important virulence factors of
this fungus. We observed that microplusin completely inhibited fungal melan-
ization, and this effect correlates with the inhibition of the related enzyme lac-
case. Also, microplusin significantly inhibited the capsule size of C. neoformans.
Our studies reveal, for the first time, a copper-chelating antimicrobial peptide
that inhibits respiration and growth of C. neoformans and modifies two major
virulence factors: melanization and formation of a polysaccharide capsule.
These features suggest that microplusin, or other copper-chelation approaches,
may be a promising therapeutic for cryptococcosis.
Introduction
Cryptococcus neoformans affects both immunocompetent
and immunocompromised individuals, especially patients
with advanced HIV infection, with transplanted organs or
treated with high doses of corticosteroids (Perfect &
Casadevall, 2002). The fungus is responsible for over
600 000 deaths per year worldwide (Park et al., 2009)
and is the primary cause of death for systemic mycoses in
HIV-infected patients in Brazil (Park et al., 2009; Prado
et al., 2009). In general, cryptococcal infections are trea-
ted with an initial administration of amphotericin B in
combination with flucytosine followed by azole deriva-
tives, such as fluconazole (Perfect et al., 2010). The
inconvenience of these therapies lies in their negative side
effects for the patient, and to a lesser extent, the develop-
ment of drug resistance by the fungus (Perfect & Casa-
devall, 2002; Dan & Levitz, 2006).
The ability of C. neoformans to infect humans is related
to several virulence factors and the two most important
are the melanin synthesis (Zhu & Williamson, 2004) and
the production of a polysaccharide capsule (Zaragoza
et al., 2009). Melanin synthesis depends on laccase activ-
ity, a copper-containing oxidase that requires exogenous
cathecolamines as substrate (Williamson et al., 1998;
Zhu & Williamson, 2004). Melanization protects the fun-
gus against oxidative stress, extremes of temperature,
enzymatic degradation, and antimicrobial compounds
(reviewed in Nosanchuk & Casadevall, 2003, 2006). The
polysaccharide capsule protects C. neoformans against
phagocytosis and induces strong immunomodulatory
responses that promote immune evasion and survival
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within the host (reviewed in Zaragoza et al., 2009). Cap-
sule enlargement occurs by self-aggregation of glucurono-
xylomannan (GXM) fibers that represent 90–95% of
capsular contents. The cross-linking between the anionic
polysaccharide chains of GXM depends on the presence
of divalent cations, such as calcium II and magnesium II
(Nimrichter et al., 2007).
Several studies have shown a relation between copper
homeostasis and virulence of C. neoformans. Essential
metabolic enzymes, such as Cu/Zn superoxide dismutase
and the high-affinity iron transporter Fet3 have been
described as copper-dependent proteins in C. neoformans
(Davis-Kaplan et al., 1998; Cox et al., 2003). High con-
centrations of exogenous copper induce laccase expression
and production of melanin in C. neoformans, and CnLac1
laccase gene induction by copper is regulated by the cop-
per-dependent transcription factor 1 (CUF1) (Jiang et al.,
2009). Also, the expression of the high-affinity fungal
copper transporter CTR4 in C. neoformans is upregulated
by CUF1 in conditions of low copper availability, such as
the environment of infected macrophages or within brain
tissue (Waterman et al., 2007). Mutants for Cuf1 display
a severe growth defect and a decrease in laccase activity
(Waterman et al., 2007). Moreover, the copper trans-
porter CTR4 is also regulated by the transcription factor
Rim101 and rimΔ C. neoformans mutants are unable to
produce large capsules (O’Meara et al., 2010).
Microplusin is a copper II and iron II chelating peptide
isolated from the cattle tick Riphicephalus (Boophilus) mi-
croplus (Fogaca et al., 2004; Esteves et al., 2009; Silva
et al., 2009). The peptide is formed as a single globular
domain with five a-helices, and although we have not yet
determined the residues involved in its copper-biding site,
our data has suggested that N-terminal residues and His-
74 are the main candidates. Moreover, microplusin has a
broad antimicrobial spectrum of activity against several
Gram-positive bacteria and fungi (Silva et al., 2009). Our
data suggest that the antibacterial activity of microplusin
against Micrococcus luteus is related to its copper-chelat-
ing activity. In fact, we observed that microplusin affects
bacterial respiration, a process that involves several heme-
copper oxidases (Silva et al., 2009). Among the fungi
previously evaluated, microplusin was active against
C. neoformans, with an MIC50 (minimal inhibitory
concentration that prevented 50% of the growth) of
0.09 lM. In the present work, we demonstrate that
microplusin is a fungistatic peptide that negatively affects
the respiration of C. neoformans. In addition, microplusin
showed inhibitory activity against two important viru-
lence factors, melanization and polysaccharide capsule
formation. Our results suggest that the anticryptococcal
action of microplusin is strongly related to its copper-
chelating ability.
Materials and methods
Microplusin
In all experiments, we used recombinant microplusin
obtained as previously described (Esteves et al., 2009).
Briefly, a mid-log phase culture of Escherichia coli (strain
BL21) containing the microplusin cDNA/pRSET-A plas-
mid (Invitrogen) was induced with 0.8 mM IPTG
(isopropyl b-D-thiogalactoside) during 4 h. Cells were
harvested at 10 000 g for 10 min at 4 °C, suspended in
phosphate-buffered saline 1 (PBS 1; 500 mM NaCl,
20 mM NaH2PO4; pH 7.5) and lysed by sonication (Bran-
son Digital Soniﬁer, Model 450). The bacterial lysate was
centrifuged once again and the recombinant fusion protein
was puriﬁed using a HisTrap™ Quelating HP column
(Amersham Biosciences) equilibrated with 100 mM
Ni2SO4. Elution was performed with 500 mM imidazole
in PBS 1 and the fusion protein was dialyzed against
100 mM Tris-HCl, pH 8.5. To cleave the His6-tag from
microplusin, fusion protein was incubated with trypsin
type-III from bovine pancreas (Sigma-Aldrich) at an
enzyme/protein molar ratio of 1 : 50 for 18 h at 37 °C.
Recombinant microplusin was puriﬁed by RP-HPLC using
a semi-preparative C18 column (Vydac™, 300 Å,
10 mm 9 250 mm) with a linear gradient of 2–60% ace-
tonitrile in acidiﬁed water over 60 min at a ﬂow rate of
1.3 mL min1. The molecular mass of recombinant
microplusin was analyzed on a LCQ Duo™ mass spectro-
meter (ThermoFinnigan).
Microorganisms
The following strains of C. neoformans were used in this
work: serotype A strains T1444 (Barbosa et al., 2007) and
H99 (Frases et al., 2007), and serotype D strain B3501
(Frases et al., 2007). The strains were cultivated for 48 h
while shaking at 30 °C in Sabouraud dextrose medium
(Difco Laboratories). Yeast cells were harvested by cen-
trifugation, washed three times with saline phosphate
buffer 2 (PBS 2: 137 mM NaCl, 2.6 mM KCl, 10 mM
NaH2PO4, 1.8 mM KH2PO4; pH 7.4) and quantified
using a Neubauer chamber. For all experiments, except
for oxygen consumption measurements, cell density was
set for 1 9 104 yeast cells per mL of medium. All experi-
ments in this work were repeated at least twice to gener-
ate triplicate sets.
Antifungal activity assay
Cryptococcus neoformans strain H99 was incubated with
or without 10 lM of microplusin (MP-treated and non-
MP treated, respectively) in potato dextrose broth (PDB)
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(Silva et al., 2009) for 72 h at 30 °C. After this period,
cells were washed and quantified as previously described.
One hundred cells from each experimental condition in
PBS 2 at a final volume of 100 lL were plated on Sabou-
raud agar medium (Difco Laboratories). After 48 h at
30 °C, the number of colony-forming units (CFU) was
determined. To investigate the effect of copper on the
growth of MP-treated C. neoformans, a liquid growth
inhibition assay was prepared as previously described
(Silva et al., 2009) by incubating C. neoformans strain
H99 in PDB medium supplemented with serial dilutions
of microplusin (25–0.19 lM) with or without 2.5 lM of
CuCl2.6H2O. C. neoformans without any treatment or
treated only with 2.5 lM of CuCl2.6H2O was used as the
yeast growth parameters for MP-treated and MP-treated
+ copper conditions, respectively. After 48 h of incuba-
tion at 30 °C, yeast growth was evaluated by absorbance
readings at 595 nm and the values obtained were trans-
formed as values of percentage of growth inhibition.
Melanization assay
A previously described protocol was used to evaluate the
effect of microplusin on melanization (Martinez et al.,
2007). Briefly, in 96-well microplates, C. neoformans strains
H99 and B3501 were incubated with or without serial dilu-
tions of microplusin (50–0.09 lM) in chemically defined
medium (CD; 15 mM glucose, 10 mM MgSO4, 29.4 mM
KH2PO4, 13 mM glycine, and 3 lM thiamine; pH 5.5)
containing 1 mM of L-dopa as a substrate for melaniza-
tion. The cultures were maintained at 30 °C, protected
from light, and melanization was monitored visually dur-
ing the incubation period. In addition, the effect of copper
supplementation on melanization of MP-treated yeast cells
was evaluated by incubating the C. neoformans strain
B3501 in CD with L-dopa and 2.5 lM of CuCl2.6H2O.
L-dopa autopolymerization assay
The autopolymerization assay was done following a meth-
odology previously described (Nosanchuk et al., 2001).
Briefly, a solution of 1 mM of L-dopa in PBS 2 was incu-
bated with different concentrations of microplusin (50–
0.38 lM) and kept at room temperature. After 3 and
20 days of incubation, absorbance was measured at
270 nm in an Ultraspec 2000 spectrophotometer (Phar-
macia Biotech). A L-dopa 1 mM solution in PBS 2 was
used as control for 100% of autopolymerization.
Laccase activity assay
The effect of microplusin on laccase activity was investi-
gated by a quantitative assay using the oxidation of
2,2′-azino-bis(3-ethylbenzothiazoline-sulfonic acid) (ABTS;
Sigma) (Martinez et al., 2007). Briefly, C. neoformans
strain H99 was grown in asparagine medium [AM; 0.1%
asparagine, 10 mM Na2PO4 (pH 6.5), 0.01% MgSO4,
50 mM CaCl2] with 0.15% glucose for 24 h at 30 °C.
Yeast cells were harvested by centrifugation, washed twice
with PBS 2, washed once with AM without glucose, and
suspended in the AM supplemented with 25 lM of mi-
croplusin. A control without microplusin was also pre-
pared. After 48 h of incubation at 30 °C, yeast cells were
collected by centrifugation, washed twice in PBS 2 and
incubated in an ABTS 1 mM solution in PBS 2 for 24 h.
To measure ABTS oxidation, yeast cells were removed by
centrifugation and the absorbance of the supernatants
was measured at 405 nm.
Capsule enlargement assay
To evaluate the effect of microplusin on capsule enlarge-
ment, C. neoformans strains H99, B3501, and T1444 were
suspended in capsule inducing medium [10% Sabouraud
dextrose media (Sab; Difco Laboratories), 50 mM MOPS
(Sigma, St. Louis, MO), pH 7.3; (Zaragoza & Casadevall,
2004)] and incubated in 96-well microplates with serial
dilutions of microplusin (25–0.78 lM) for 48 h at 37 °C.
Control cultures without microplusin were also per-
formed. Yeast cells were harvested by centrifugation and
stained with India ink (Becton Dickinson, NJ). Cells were
observed in an Axiovert 200 M inverted microscope and
photographed with an AxiocamMR camera controlled by
the AXION VISION 4.4 software (Carl Zeiss Micro Imaging,
NY). Images were analyzed using the IMAGEJ software
(W. S. Rasband, National Institutes of Health, Bethesda,
MD) (http://rsb.info.nih.gov/ij/) and the capsule size was
defined as the distance between the cell wall and the
outer border of the capsule (Barbosa et al., 2007).
Oxygen consumption measurements
Oxygen consumption of C. neoformans was measured
polarographically at 30 °C using a computer-interfaced
Clark-type electrode in PDB media in a final volume of
1 mL and at 6 9 106 yeast cells mL1 of cell density.
C. neoformans was grown at 30 °C in PDB either for 24 h
without 10 lM microplusin (non-MP treated) or for
48 h with 10 lM microplusin (MP-treated) to use the
fungus at the same concentration in culture, around
3 9 107–5 9 107 yeast cells mL1. The electrode was first
stabilized at zero oxygen consumption in fresh PDB with
constant stirring in the thermo-balanced chamber at 30 °C
before the fungal suspension was transferred to the cham-
ber. Recordings of respiration rate were initiated after
closing the chamber with an air-tight lid. At least 10 min
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after initiating the recording of basal respiration, 4 lM of
the uncoupler carbonyl cyanide m-chlorophenylhydraz-
one, 4 lM of the alternative oxidase (AOX) inhibitor
salycil-hydroxamic acid (SHAM) and/or 4 lM of the
complex III respiratory inhibitor antimycin A (AA), or
1 lM of the complex IV respiratory inhibitor potassium
cyanide (KCN) were added to the chamber containing
C. neoformans. Values are represented as the rate of O2
consumption in nanomoles min1 ± SD.
Statistical analysis
Statistical analysis was performed using PRISM version 5
(GraphPad Software). The results were compared by Stu-
dent’s t-test or two-way ANOVA test according to the data.
Results
Microplusin has a fungistatic effect against
C. neoformans
In a previous study, we showed by absorbance readings
(A595 nm) that 0.09 lM of microplusin inhibited 50% of
the growth of C. neoformans (Silva et al., 2009). However,
we did not determine whether microplusin was fungicidal
or fungistatic. We addressed this question by incubating
C. neoformans (strain H99) with 10 lM microplusin. After
72 h incubation, the number of MP-treated yeast cells was
10-fold lower compared with non-MP treated cells
(Fig. 1a). A similar result was obtained after 48-h incuba-
tion with microplusin (data not shown). To determine the
viability of C. neoformans after exposure to MP, 100 yeast
cells (MP-treated and non-MP treated systems) were pla-
ted onto Sabouraud agar medium. Although there was a
trend toward a reduction in CFU after 48-h incubation in
MP-treated cells, the CFU determinations were not signifi-
cantly different (P-value = 0.1710) between the two
culture conditions (Fig. 1b). Hence, microplusin predomi-
nantly has a fungistatic effect against C. neoformans. In
addition, supplementation of PDB medium with 2.5 lM
of CuCl2.6H2O significantly impaired microplusin’s activ-
ity against C. neoformans (Fig. 2). The protective effect of
copper depended on the concentration of microplusin, as
the inhibitory action of the compound was most pro-
nounced at microplusin concentrations  1.56 lM.
Effect of microplusin on oxygen consumption
To test whether the copper depletion promoted by micro-
plusin affected complex IV functioning, and therefore
electron flow through classical respiratory pathway, we
measured oxygen consumption of C. neoformans in the
presence of different inhibitors of the electron transport
complexes. In non-treated C. neoformans, electrons flow
largely via the classical pathway, since inhibition of either
complex III/cytochrome c reductase with 4 lM AA or
complex IV/cytochrome oxidase with 1 lM KCN
decreased oxygen consumption by ~70% (Fig. 3). In these
non-treated fungi, inhibition of the AOX of the alterna-
tive respiratory pathway with 4 lM SHAM did not affect
the rate of oxygen consumption, although it fully abro-
gated respiration in combination with AA. Microplusin
completely altered the respiratory profile of C. neofor-
mans. The basal oxygen consumption in MP-treated cells
was approximately 40% lower than that in non-MP trea-
ted cells. In treated fungi, AA or KCN did not further
disturb the rate of oxygen consumption, while SHAM
fully impaired respiration, which implies that the classical
electron transport pathway was either damaged or absent
Fig. 1. Effect of microplusin on Cryptococcus neoformans. Yeast cells
[strain H99 (1 9 104 cells mL1)] were incubated with 10 lM of
microplusin (MP) for 72 h at 30 °C. (a) The number of yeast cells per
mL after 72-h incubation for both non-MP treated (control) and MP-
treated conditions was determined. ***P < 0.05. (b) One hundred
cells from MP-treated and non-MP treated preparations were plated
on Sabouraud agar, and after a 48-h incubation at 30 °C, cell viability
was evaluated by CFU determination. The difference between the
number of CFU of non-MP treated and MP-treated yeast cells was
not statistically different (P = 0.1710). The experiments were repeated
twice and yielded similar results.
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and that respiration of C. neoformans is entirely driven by
the alternative pathway.
Microplusin inhibits C. neoformans
melanization
As laccase is a copper-dependent oxidase responsible for
melanization (Zhu & Williamson, 2004) in C. neoformans,
we investigated whether the copper-chelating properties
of microplusin might have a negative effect on this pro-
cess. Microplusin inhibited melanization of the strains
H99 and B3501 at concentrations  3.12 lM (Fig. 4a).
When we supplemented a culture of C. neoformans strain
B3501 with 2.5 lM of CuCl2.6H2O, we observed that the
presence of this metal caused a twofold reduction in the
antimelanization activity of microplusin (Fig. 4b). Similar
results were obtained with C. neoformans strain H99 (data
not shown). Moreover, we observed that microplusin
reduced the laccase activity of C. neoformans strain H99
by almost 50% (Fig. 4c).
In parallel, we evaluated whether microplusin could
reduce L-dopa autopolymerization in a manner similar to
glyphosate, a compound whose antimelanization activity
in C. neoformans has been described (Nosanchuk et al.,
2001). Microplusin did not inhibit the autopolymeriza-
tion of L-dopa and even increased this process at concen-
trations  6.25 lM (Fig. 4d).
Microplusin inhibits the production of
C. neoformans polysaccharide capsule
Several enzymes are involved in the formation of the
polysaccharide capsule in C. neoformans (reviewed in
Zaragoza et al., 2009) and microplusin might affect this
process by copper depletion, as copper is a co-factor for
some of these enzymes. Our results revealed that micro-
plusin impeded capsule enlargement of C. neoformans
(strain T1444) in a dose-dependent manner (Fig. 5a). We
also observed that 25 lM of microplusin significantly
inhibited the capsular enlargement of H99 and B3501
(Fig. 5b and c).
Discussion
Our main hypothesis was that microplusin could nega-
tively affect C. neoformans by copper depletion, which
would be consistent with the importance of copper
homeostasis for this fungus (Davis-Kaplan et al., 1998;
Cox et al., 2003; Zhu et al., 2003; Waterman et al., 2007;
Fig. 2. Effect of copper supplementation on the growth of
Cryptococcus neoformans. C. neoformans (strain H99) was incubated
in serial dilutions of microplusin (25–0.19 lM) without (MP) or
supplemented with 2.5 lM of CuCl2.6H2O (MP + copper) for 48 h at
30 °C. Yeast growth was determined by comparison of the growth
inhibition percentages. ***P < 0.001 in comparing the MP group
with the MP + copper group. The experiments were repeated twice
and yielded similar results.
Fig. 3. Effect of microplusin on mitochondrial electron transport chain and respiration rate. Cryptococcus neoformans (strain H99) yeast cells
were incubated in PDB media with or without 10 lM microplusin for 24–48 h at 30 °C. Oxygen consumption was monitored in the presence of
4 lM of alternative oxidase inhibitor salycil-hydroxamic acid (SHAM), 4 lM of antimycin (AA) or 1 lM KCN. Data shown represent the means
and standard errors of results from two independent experiments performed in triplicate. *P < 0.05 comparing MP-treated to non-MP-treated
yeast cells. **P < 0.01 comparing respiration under AA or KCN to basal respiration of MP-treated yeast cells. ***P < 0.001 comparing respiration
under SHAM to basal respiration of MP-treated yeast cells.
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Jiang et al., 2009) and the copper-chelating property of
microplusin at a MP : copper II molar ratio of 1 : 1 (Silva
et al., 2009). We have shown that microplusin at concen-
trations  1.56 lM significantly affected the growth of
C. neoformans, similar to the activity of the peptide against
M. luteus (Silva et al., 2009). Moreover, the anticrypto-
coccal effect was considerably reversed when 2.5 lM of
copper was added.
Notably, our results indicate the presence of both clas-
sical and alternative respiratory pathways in the C. neofor-
mans electron transport chain and suggest that the effect
of microplusin on the growth of the fungi may be related
to the damage of the classical respiratory chain, probably
at the copper-containing complex IV. Although we can-
not entirely discard the effects of Fe2+ on microplusin,
our assumption that microplusin is preferentially a cop-
per chelator is based on the fact that the four respiratory
complexes that have iron as prosthetic groups or bound
to the heme group remained functional, whereas complex
IV, the only complex that has copper as a prosthetic
group, was affected by microplusin. We also show that
microplusin stimulated the alternative respiratory path-
way in C. neoformans, likely to compensate for the dam-
aged classical electron transport chain. The alternative
pathway is not coupled to oxidative phosphorylation and
ATP synthesis, and hence, energy production in micro-
plusin-treated yeasts is likely to be deficient. However,
uncoupled respiration helps the cells to manage reactive
oxygen species production under stress conditions. Simi-
lar to complex IV, the assembly and functioning of other
copper proteins, such as the antioxidant enzyme Cu-Zn
superoxide dismutase (SOD1), might also be compro-
mised in microplusin-treated C. neoformans.
Microplusin at concentrations  3.12 lM clearly inhib-
ited C. neoformans melanization as well as reduced laccase
activity. This further suggests that the copper-chelating
ability of microplusin may affect the loading of copper
ions to laccase apoenzyme. In addition, we observed that
copper supplementation of the medium prevented the
inhibition of melanization by microplusin, according to
Fig. 4. Effect of microplusin on melanization of Cryptococcus neoformans. (a) Yeast cells were incubated with or without microplusin
(50–0.09 lM) in chemically defined medium (CD) supplemented with L-dopa; (b) strain B3501 was incubated with or without microplusin
(50–0.09 lM) in CD medium/L-dopa with or without 2.5 lM CuCl2.6H2O. (c) Quantitative laccase assay using the substrate 2,2′-azino-bis
(3-ethylbenzothiazoline-6-sulfonic acid) (ABTS) for C. neoformans strain H99 in the presence of microplusin (25 lM). **P < 0.05 comparing
MP-treated and non-MP-treated yeast cells. (d) L-dopa solution (1 mM) incubated with microplusin (25.0; 12.5; 6.25 and 3.12 lM). L-dopa (1 mM)
was used as control. Absorbance was measured after 3 and 20 days of incubation. The absorbance of samples incubated with microplusin
(L-dopa + MP) was compared to the control without the peptide (L-dopa). **P < 0.05. The experiments were repeated twice and yielded similar
results.
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1 : 1 binding ratio (Silva et al., 2009). A correct laccase
metallation is reportedly crucial for its biological activity,
as shown for the laccase produced by the avirulent Dvph1
mutant of C. neoformans. Defective vesicular acidification
disrupts the insertion of copper cofactors into proteins,
resulting in the inability of Dvph1 laccase to catalyze phe-
nolic compounds to melanin (Erickson et al., 2001). As
expected, addition of 1 mM of the copper chelator BCS
to the medium abolished laccase activity not only in the
Dvph1 mutant but also in the wild-type strain and copper
supplementation, restored laccase activity as well as
induced its transcription (Zhu et al., 2003). Therefore,
these data support the hypothesis that microplusin
sequesters copper and may affect the availability of this
metal to copper-dependent enzymes, such as laccase.
The microplusin concentrations that inhibited melan-
ization ( 3.12 lM) also increased the autopolymeriza-
tion of L-dopa. L-dopa autopolymerization is a process
that occurs spontaneously by exposure to light (Mason,
1955). Microplusin probably stimulates the spontaneous
autopolymerization of the products derived from L-dopa
oxidation; however, this possible action did not interfere
with its inhibitory effect on melanization of C. neofor-
mans in the absence of light.
Capsule enlargement in C. neoformans requires extra-
cellular deliverance of GXM, which is further incorpo-
rated into the fungal cell surface to promote distal
capsular growth (reviewed in Zaragoza et al., 2009). The
subsequent self-aggregation of polysaccharide molecules
occurs by mechanisms that putatively require divalent
cations, such as calcium II (Nimrichter et al., 2007). The
inhibitory activity of microplusin on capsular enlarge-
ment could be due to the interference with aggregation of
the building blocks through metal chelation, thereby
affecting the correct polysaccharide capsule assembly.
However, based on our mass spectrometry analysis,
microplusin does not bind calcium II (Silva et al., 2009).
Thus, its effect on capsule enlargement most likely results
from inhibition of one or more metabolic processes
dependent on enzymes that requires copper as a cofactor.
Notably, the Dvph1 mutant also had aberrant capsular
production (Li & Kaplan, 1998; Erickson et al., 2001).
Fig. 5. Effect of microplusin on the formation of the polysaccharide capsule of Cryptococcus neoformans. (a) Measurement of capsule size in
C. neoformans (strain T1444) incubated with serial dilutions of microplusin (25.0–0.78 lM) for 48 h at 37 °C. (b) Capsular dimensions of
C. neoformans (strains H99 and B3501) after incubation with 25 lM microplusin for 48 h at 37 °C. (c) Capsule morphology of C. neoformans
(strain H99) after exposure to microplusin. Scale bar: 10 lm. MP-treated: yeast cells treated with microplusin; non-MP-treated: control without
microplusin. The experiments were repeated twice with similar results. ***P < 0.05 comparing MP-treated to non-MP-treated yeast cells (control).
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In conclusion, microplusin showed a noteworthy fungi-
static activity in vitro against C. neoformans. We demon-
strate that this effect may be related to its inhibitory effect
on the classical respiratory pathway of C. neoformans.
Microplusin also affected the two most important viru-
lence factors of this mycopathogen: the melanization pro-
cess and the formation of a polysaccharide capsule. These
findings are particularly relevant for determining the util-
ity of copper-chelator compounds, like microplusin as a
therapeutic for cryptococcosis. However, studies in vivo
are crucial to corroborate the efficiency of this peptide or
other metal chelators for combating C. neoformans.
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